As of May 2022 Charles River Laboratories has a market cap of $11.77 Billion. This makes Charles River Laboratories the world's 1277th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to mesure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2022 | $11.98 B | -36.99% |
2021 | $19.01 B | 52.98% |
2020 | $12.42 B | 66.26% |
2019 | $7.47 B | 37.01% |
2018 | $5.45 B | 5.26% |
2017 | $5.18 B | 43.75% |
2016 | $3.60 B | -3.94% |
2015 | $3.75 B | 24.64% |
2014 | $3.01 B | 19.41% |
2013 | $2.52 B | 39.6% |
2012 | $1.80 B | 33.72% |
2011 | $1.35 B | -32.64% |
2010 | $2.00 B | -9.62% |
2009 | $2.21 B | 25.16% |
2008 | $1.77 B | -60.45% |
2007 | $4.48 B | 54.9% |
2006 | $2.89 B | -5.6% |
2005 | $3.06 B | 1.29% |
2004 | $3.02 B | 92.5% |
2003 | $1.57 B | -9.64% |
2002 | $1.74 B | 15.05% |
2001 | $1.51 B |
On May 19th, 2022 the market cap of Charles River Laboratories was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Thermo Fisher Scientific TMO | $215.59 B | 1,730.94% | ๐บ๐ธ USA |
![]() SCYNEXIS SCYX | $0.06 B | -99.42% | ๐บ๐ธ USA |
![]() Repligen
RGEN | $8.57 B | -27.21% | ๐บ๐ธ USA |